California Attorney General sues drugmakers over inflated insulin prices
California Attorney General Rob Bonta on Thursday, January 12 sued the six major companies that dominate the U.S. insulin market, ratcheting up the state’s assault on a profitable industry for artificially jacking up prices and making the indispensable drug less accessible for diabetes patients. The 47-page civil complaint alleges three pharmaceutical companies that control the insulin market…